Skip links and keyboard navigation

Vaccine preventable disease surveillance

Queensland Health has established surveillance systems for the following vaccine preventable diseases:

  • Diphtheria
  • Group A streptococcal infection (invasive)*
  • Haemophilus influenzae type B (invasive)
  • Measles
  • Meningococcal disease (invasive)
  • Mumps
  • Pertussis
  • Pneumococcal disease (invasive)
  • Poliomyelitis
  • Rotavirus
  • Rubella
  • Tetanus
  • Varicella

Queensland Health also has a surveillance reporting resource for influenza.

Data on cases is reported to the Notifiable Conditions System by onset date of disease and published weekly in the Notifiable conditions report.

Surveillance case definitions for each disease are available in the relevant Queensland Health guidelines.

Read more about Queensland's immunisation program.

(*Group A streptococcal infections are not vaccine preventable but are included on this page for reporting of invasive diseases.)

Surveillance Reports

Quarterly report on vaccine preventable and invasive diseases

A quarterly report is prepared on vaccine preventable and invasive diseases notified in Queensland. This report contains additional data to that provided in the weekly reporting including trends, age groups, serotype and serogroup data where relevant.


Rotavirus in Queensland, 2006-2017( PDF, 2.0MB)

National resources

National data and reports

Data on vaccine preventable diseases is collected and reported nationally

National immunisation program (NIP)

Queensland participates in the National Immunisation Program (NIP) which funds the purchase of vaccines to protect Australians from vaccine preventable diseases. The program currently includes vaccines for 16 diseases and these are administered through state based immunisation programs.

Request information

The release of notifiable conditions data by Queensland Health is governed by processes which protects the privacy and confidentiality of individuals.

Access to and use of notifiable conditions data requires an assessment before approval to release.

The guidelines and request form (PDF 237 kB) provides details about the application process.

Last updated: 16 February 2022